Slice Technical Monograph (pdf, 2083 kb)
Monograph Cover
Slice Usage Guidelines (pdf, 1260 kb)
Usage Guide Cover

0.2% Emamectin Benzoate Medicated Feed Premix

For the treatment and prevention at group level of infestations of all parasitic stages of sea lice (Lepeophtheirus sp. and Caligus sp.) on Atlantic salmon (Salmo salar) ranging in size from smolts in freshwater (just prior to transfer to seawater) to market weight fish in seawater.

Dosage and Administration

Medicated feed is prepared by coating SLICE Premix onto the surface of non-medicated fish feed pellets.

Administer at 50μg active/kg fish biomass/day for seven consecutive days.

Withdrawal time: **

Product Presentation:
SLICE Premix is supplied in 2.5 kg sachets containing 5 g of emamectin benzoate (0.2% w/w).

Pharmacologic Properties:
Emamectin is an avermectin compound derived synthetically from avermectins which are produced by fermentation of the soil organism Streptomyces avermitilis. The benzoate salt confers stability on the molecule. When fed to fish emamectin benzoate is absorbed from the gut and distributed to the tissue of the fish. When sea lice feed on tissues of treated fish, emamectin is taken up into the tissues of the louse. Emamectin then binds to ion channels of nerve cells and disrupts transmission of nerve impulses, which results in paralysis and death of the parasite. Emamectin benzoate is excreted slowly by fish and metabolized to inactive compounds, resulting in long-lasting protection.

**Withdrawal times may vary from country to country.

This website contains information on veterinary pharmaceutical and biological products based on international registration dossiers. The site may refer to products that are either not available in your country or are marketed under a different tradename. In addition, the safety and efficacy data and the withholding periods for a specific product may be different depending on local regulations. Please consult your veterinarian for further information.